1. Home
  2. NVCR vs LSPD Comparison

NVCR vs LSPD Comparison

Compare NVCR & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LSPD
  • Stock Information
  • Founded
  • NVCR 2000
  • LSPD 2005
  • Country
  • NVCR Switzerland
  • LSPD Canada
  • Employees
  • NVCR N/A
  • LSPD N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LSPD
  • Sector
  • NVCR Health Care
  • LSPD
  • Exchange
  • NVCR Nasdaq
  • LSPD Nasdaq
  • Market Cap
  • NVCR 1.9B
  • LSPD 1.6B
  • IPO Year
  • NVCR 2015
  • LSPD 2020
  • Fundamental
  • Price
  • NVCR $17.77
  • LSPD $11.73
  • Analyst Decision
  • NVCR Buy
  • LSPD Buy
  • Analyst Count
  • NVCR 7
  • LSPD 13
  • Target Price
  • NVCR $32.43
  • LSPD $13.42
  • AVG Volume (30 Days)
  • NVCR 1.5M
  • LSPD 672.7K
  • Earning Date
  • NVCR 07-24-2025
  • LSPD 07-31-2025
  • Dividend Yield
  • NVCR N/A
  • LSPD N/A
  • EPS Growth
  • NVCR N/A
  • LSPD N/A
  • EPS
  • NVCR N/A
  • LSPD N/A
  • Revenue
  • NVCR $621,711,000.00
  • LSPD $1,076,826,000.00
  • Revenue This Year
  • NVCR $5.56
  • LSPD $13.02
  • Revenue Next Year
  • NVCR $9.19
  • LSPD $16.19
  • P/E Ratio
  • NVCR N/A
  • LSPD N/A
  • Revenue Growth
  • NVCR 18.27
  • LSPD 18.43
  • 52 Week Low
  • NVCR $14.17
  • LSPD $7.34
  • 52 Week High
  • NVCR $34.13
  • LSPD $18.96
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.02
  • LSPD 56.95
  • Support Level
  • NVCR $16.81
  • LSPD $11.52
  • Resistance Level
  • NVCR $18.70
  • LSPD $11.92
  • Average True Range (ATR)
  • NVCR 0.73
  • LSPD 0.32
  • MACD
  • NVCR 0.04
  • LSPD -0.01
  • Stochastic Oscillator
  • NVCR 62.75
  • LSPD 84.10

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.

Share on Social Networks: